Gold Mining News – Lifestyle
Home
Sample Page
Author:
OPKO Health, Inc.
OPKO Health’s ModeX Therapeutics Will Present Data Demonstrating In Vivo CAR-T Cell Generation and Deep B-Cell Depletion in Preclinical Studies
May 12, 2026
BioReference® Launches BioReference Direct™, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital Platform
April 30, 2026
OPKO Health Expands Nicoya Agreement to Support RAYALDEE® Commercialization in Greater China
April 30, 2026
OPKO Health Reports First Quarter 2026 Business Highlights and Financial Results
April 28, 2026
OPKO Health’s ModeX Therapeutics Begins Clinical Trial of Tetraspecific Antibody for Treatment of B-cell Lymphomas
April 22, 2026
OPKO Health to Report First Quarter 2026 Financial Results on April 28, 2026
April 21, 2026
OPKO Health’s ModeX Therapeutics Initiates Clinical Trial of MDX2301 for the Prevention of COVID-19
April 8, 2026